ThinkCyte expands portfolio to accelerate drug discovery and disease research

ThinkCyte has unveiled its groundbreaking VisionCyte platform, which combines high-resolution morphological profiling, high-throughput capabilities, and advanced AI-powered analysis to revolutionize drug discovery. By facilitating the identification of novel biomarkers and uncovering diversified hits and targets, VisionCyte is set to transform how researchers approach drug development. The platform will undergo a full commercial rollout in 2025, with an initial batch of customer-ready units expected to be available in the second half of the year.

In addition to VisionCyte, the company introduced its Celluminate cell tracking kits, designed to complement both the VisionSort and VisionCyte platforms. These innovative kits target discovery applications in areas where conventional cell surface markers are inadequate, such as specific hematological conditions, stem cell research, and age-related diseases. By addressing these critical gaps, Celluminate enables researchers to delve deeper into cellular behaviors and mechanisms, providing enhanced tools for exploring complex biological systems.

Waichiro Katsuda, Chief Executive Officer at ThinkCyte, emphasized the company’s dedication to advancing life sciences: "The expansion of our product portfolio reflects our unwavering commitment to supporting scientific innovation. By introducing solutions that cater to the evolving needs of researchers worldwide, we're not merely offering new products—we're equipping scientists with the tools they need to accelerate discoveries, deepen our understanding of diseases, and improve patient outcomes."

This dual launch underscores ThinkCyte’s mission to address the challenges of modern research by combining cutting-edge technology with practical applications. VisionCyte and Celluminate are poised to support breakthroughs in areas such as biomarker discovery, personalized medicine, and disease modeling, paving the way for a new era of drug discovery and biomedical research. With these advancements, ThinkCyte aims to empower scientists to unlock new possibilities and redefine what’s achievable in the life sciences industry.